Blood pressure response to type A endothelin receptor antagonism in human obesity and diabetes mellitus.
Han
K A
KA
1Eulji University, Seoul, Korea.
Lteif
A A
AA
Mather
K J
KJ
D000328:Adult; D000959:Antihypertensive Agents / Q000008:administration & dosage*; D001794:Blood Pressure / Q000187:drug effects*; D003920:Diabetes Mellitus / Q000188:drug therapy / Q000503:physiopathology*; D065130:Endothelin A Receptor Antagonists; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009765:Obesity / Q000188:drug therapy / Q000503:physiopathology*; D010456:Peptides, Cyclic / Q000008:administration & dosage*
D000959:Antihypertensive Agents; D065130:Endothelin A Receptor Antagonists; D010456:Peptides, Cyclic; C072247:cyclo(Trp-Asp-Pro-Val-Leu)